https://orcid.org/0000-0003-0707-9009
References
- Akinbami LJ, Moorman JE, Bailey C, et al. NCHS Data Brief, Number 94, May 2012. http://www.cdc.gov/nchs/data/databriefs/db94_tables.pdf#2. Accessed November 5, 2019.
- Sullivan J, Pravosud V, Mannino DM, Siegel K, Choate R, Sullivan T. National and state estimates of COPD morbidity and mortality – United States, 2014-2015. Chronic Obstr Pulm Dis 2018;5(4):324–333. doi:https://doi.org/10.15326/jcopdf.5.4.2018.0157.
- Tinkelman D, Price D, Nordyke R, Halbert R. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006;43(1):75–80. doi:https://doi.org/10.1080/02770900500448738
- Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, et al. Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices. Ann Am Thorac Soc. 2019;16(9):1143–1150. doi:https://doi.org/10.1513/AnnalsATS.201809-607OC
- McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother 2010;24(1):5–18. doi:https://doi.org/10.3109/15360280903544877
- Morse S, Bride BE. Decrease in healthcare utilization and costs for opioid users following residential integrated treatment for co-occurring disorders. Healthcare (Basel, Switzerland) 2017;5(3):54. doi:https://doi.org/10.3390/healthcare5030054
- Buster MCA, Rook L, Van Brussel GHA, Van Ree J, Van Den Brink W. Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 2002; 68:221–228 doi:https://doi.org/10.1016/S0376-8716(02)00193-X.
- Burhan H, Young R, Byrne T, Peat R, Furlong J, Renwick S, Elkin T, Oelbaum S, Walker PP. Screening heroin smokers attending community drug services for COPD. Chest 2019;155(2):279–287. doi:https://doi.org/10.1016/j.chest.2018.08.1049
- Vlies B, Lewis-Burke N, Davies L, Walker P. P247 the prevalence of asthma and level of treatment in current or former heroin smokers. Thorax 2015;70(Suppl 3):A201. doi:https://doi.org/10.1136/thoraxjnl-2015-207770.383
- Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003;123(2):510–517. doi:https://doi.org/10.1378/chest.123.2.510.
- Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 2005;128(4):1951–1957. doi:https://doi.org/10.1378/chest.128.4.1951
- Rome LA, Lippmann ML, Dalsey WC, Taggart P, Pomerantz S. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000;117(5):1324–1329. doi:https://doi.org/10.1378/chest.117.5.1324
- Levenson T, Greenberger PA, Donoghue ER, Lifschultz BD. Asthma deaths confounded by substance abuse. An assessment of fatal asthma. Chest 1996;110(3):604–610. doi:https://doi.org/10.1378/chest.110.3.604.
- Choi H, Krantz A, Smith J, Trick W. Medical diagnoses associated with substance dependence among inpatients at a large urban hospital. PLoS One 2015;10(6):e0131324. doi:https://doi.org/10.1371/journal.pone.0131324
- Yadavilli R, Collins A, Ding WY, Garner N, Williams J, Burhan H. Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers. Lung 2014;192(5):669–673. doi:https://doi.org/10.1007/s00408-014-9632-3
- NRD Overview. https://www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed August 31, 2020.
- Healthcare Cost and Utilization Project. Elixhauser Comorbidity Software, Version 3.7. https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed June 5, 2019.
- Healthcare Cost and Utilization Project. Cost-to-Charge Ratio Files. us.ahrq.gov/db/state/costtocharge.jsp. Accessed June 5, 2019.
- National Income Product Accounts Tables. Section 1 Domestic Product and Income, Table 1.1.4 Price Indexes for Gross Domestic Products. Bureau of Economic Analysis. https://apps.bea.gov/iTable/iTable.cfm?reqid=19&step=2#reqid=19&step=2&isuri=1&1921=survey. Accessed June 5, 2019.
- Lacasse Y, Daigle J-M, Martin S, Maltais F. Validity of chronic obstructive pulmonary disease diagnoses in a large administrative database. Can Respir J 2012; 19(2):e5–e9. doi:https://doi.org/10.1155/2012/260374.
- Healthcare Cost and Utilization Project. HCUP Methods Series. Calculating Nationwide Readmissions Database (NRD) Variances. https://www.hcup-us.ahrq.gov/reports/methods/2017-01.pdf. Accessed June 5, 2019.
- Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, Soler N, Torres A. Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLoS One. 2016;11(3):e0150737. doi:https://doi.org/10.1371/journal.pone.0150737.
- Readmissions-Reduction-Program. https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Published 2019. Accessed January 28, 2019.
- Polubriaginof F, Salmasian H, Albert DA, Vawdrey DK. Challenges with collecting smoking status in electronic health records. AMIA Annu Symp Proc. 2017; 2017:1392–1400.
- Zhao J, Stockwell T, Macdonald S. Non-response bias in alcohol and drug population surveys. Drug Alcohol Rev. 2009; 28(6):648–657. doi:https://doi.org/10.1111/j.1465-3362.2009.00077.x.
- Parthasarathy S, Weisner C, Hu TW, Moore C. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. J Stud Alcohol. 2001;62(1):89–97. doi:https://doi.org/10.15288/jsa.2001.62.89.
- Holder HD. Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. J Mental Health Policy Econ. 1998;1(1):23–29. doi:https://doi.org/10.1002/(SICI)1099-176X(199803)1:1<23::AID-MHP3>3.0.CO;2-Q.